|
1
|
Aupérin A: Epidemiology of head and neck
cancers: An update. Curr Opin Oncol. 32:178–186. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Newman JR, Connolly TM, Illing EA, Kilgore
ML, Locher JL and Carroll WR: Survival trends in hypopharyngeal
cancer: A population-based review. Laryngoscope. 125:624–629.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Buckley JG and MacLennan K: Cervical node
metastases in laryngeal and hypopharyngeal cancer: A prospective
analysis of prevalence and distribution. Head Neck. 2:380–385.
2000.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cooper JS, Porter K, Mallin K, Hoffman HT,
Weber RS, Ang KK, Gay EG and Langer CJ: National Cancer Database
report on cancer of the head and neck:10-year update. Head Neck.
31:748–758. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Eckel HE and Bradley PJ: Treatment options
for hypopharyngeal cancer. Adv Otorhinolaryngol. 83:47–53.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sewnaik A and Baatenburg de Jong RJ:
Sequelae and complications of treatment for hypopharyngeal cancer:
Minimising the risks. Adv Otorhinolaryngol. 83:109–117.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mahalingam S and Spielmann P: Quality of
life outcomes following treatment of hypopharyngeal cancer. Adv
Otorhinolaryngol. 83:126–134. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
van den Bosch S, Czerwinski M, Govers T,
Takes RP, de Bree R, Al-Mamgani A, Hannink G and Kaanders JHAM:
Diagnostic test accuracy of sentinel lymph node biopsy in squamous
cell carcinoma of the oropharynx, larynx, and hypopharynx: A
systematic review and meta-analysis. Head Neck. 44:2621–2632.
2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Horváth A, Prekopp P, Polony G, Székely E,
Tamás L and Dános K: Accuracy of the preoperative diagnostic workup
in patients with head and neck cancers undergoing neck dissection
in terms of nodal metastases. Eur Arch Otorhinolaryngol.
278:2041–2046. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Freiser ME, Ojo RB, Lo K, Saint-Victor S,
Bollig C, Nayak CS and Sargi ZB: Complications and oncologic
outcomes following elective neck dissection with salvage
laryngectomy for the N0 neck. Am J Otolaryngol. 37:186–194.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hardisson D: Molecular pathogenesis of
head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol.
260:502–508. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rickman DS, Millon R, De Reynies A, Thomas
E, Wasylyk C, Muller D, Abecassis J and Wasylyk B: Prediction of
future metastasis and molecular characterization of head and neck
squamous-cell carcinoma based on transcriptome and genome analysis
by microarrays. Oncogene. 27:6607–6622. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Elsheikh MN, Rinaldo A, Hamakawa H,
Mahfouz ME, Rodrigo JP, Brennan J, Devaney KO, Grandis JR and
Ferlito A: Importance of molecular analysis in detecting cervical
lymph node metastasis in head and neck squamous cell carcinoma.
Head Neck. 28:842–849. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gupta KK, Li C, Duan A, Alberico EO, Kim
OV, Alber MS and Goodson HV: Mechanism for the
catastrophe-promoting activity of the microtubule destabilizer
Op18/stathmin. Proc Natl Acad Sci USA. 110:20449–20454.
2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hsieh SY, Huang SF, Yu MC, Yeh TS, Chen
TC, Lin YJ, Chang CJ, Sung CM, Lee YL and Hsu CY: Stathmin1
overexpression associated with polyploidy, tumor-cell invasion,
early recurrence, and poor prognosis in human hepatoma. Mol
Carcinog. 49:476–487. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Cao S, Zhang W, Shen P and Xu R: Low STMN1
is associated with better prognosis in Asian patients with
esophageal cancers: A meta-analysis. J Gastroenterol Hepatol.
35:1668–1675. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen Y, Zhang Q, Ding C, Zhang X, Qiu X
and Zhang Z: Stathmin1 overexpression in hypopharyngeal squamous
cell carcinoma: A new promoter in FaDu cell proliferation and
migration. Int J Oncol. 50:31–40. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang Z, Helman JI and Li LJ:
Lymphangiogenesis, lymphatic endothelial cells and lymphatic
metastasis in head and neck cancer-a review of mechanisms. Int J
Oral Sci. 2:5–14. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ji RC: Hypoxia and lymphangiogenesis in
tumor microenvironment and metastasis. Cancer Lett. 346:6–16.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao Z, Mu H, Li Y, Liu Y, Zou J and Zhu
Y: Clinicopathological and prognostic value of hypoxia-inducible
factor-1α in breast cancer: A meta-analysis including 5177
patients. Clin Transl Oncol. 22:1892–1906. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Méndez-Blanco C, Fernández-Palanca P,
Fondevila F, González-Gallego J and Mauriz JL: Prognostic and
clinicopathological significance of hypoxia-inducible factors 1α
and 2α in hepatocellular carcinoma: A systematic review with
meta-analysis. Ther Adv Med Oncol.
13(1758835920987071)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yang YF, Chang YC, Tsai KW, Hung MH and
Kang BH: UBE2C triggers HIF-1α-glycolytic flux in head and neck
squamous cell carcinoma. J Cell Mol Med. 26:3716–3725.
2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hartiala P and Saarikko AM:
Lymphangiogenesis and lymphangiogenic growth factors. J Reconstr
Microsurg. 32:10–15. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li S and Li Q: Cancer stem cells,
lymphangiogenesis, and lymphatic metastasis. Cancer Lett.
357:438–447. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Achen MG and Stacker SA: Molecular control
of lymphatic metastasis. Ann NY Acad Sci. 1131:225–234.
2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gogineni A, Caunt M, Crow A, Lee CV, Fuh
G, van Bruggen N, Ye W and Weimer RM: Inhibition of VEGF-C
modulates distal lymphatic remodeling and secondary metastasis.
PLoS One. 8(e68755)2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hirakawa S, Kodama S, Kunstfeld R, Kajiya
K, Brown LF and Detmar M: VEGF-A induces tumor and sentinel lymph
node lymphangiogenesis and promotes lymphatic metastasis. J Exp
Med. 201:1089–1099. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Alam A, Herault JP, Barron P, Favier B,
Fons P, Delesque-Touchard N, Senegas I, Laboudie P, Bonnin J,
Cassan C, et al: Heterodimerization with vascular endothelial
growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3
activity. Biochem Biophys Res Commun. 324:909–915. 2004.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Toh Y and Nicolson GL: Identification and
characterization of metastasis-associated gene/protein 1 (MTA1).
Cancer Metastasis Rev. 33:837–842. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li P, Cao W, Ding R, Cheng M, Xu X, Chen
S, Chen B, Cao G and Xiong M: Expression and prognostic
significance of metastasis-associated protein 1 in gastrointestinal
cancer. Front Oncol. 10(542330)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liu T, Yang M, Yang S, Ge T, Gu L and Lou
G: Metastasis-associated protein 1 is a novel marker predicting
survival and lymph nodes metastasis in cervical cancer. Hum Pathol.
44:2275–2281. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Roepman P, de Jager A, Groot Koerkamp MJ,
Kummer JA, Slootweg PJ and Holstege FC: Maintenance of head and
neck tumor gene expression profiles upon lymph node metastasis.
Cancer Res. 66:11110–11114. 2006.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Guo X, Chen Y, Fang W, Yang W, Shi L and
Zhu R: Metastasis associated protein 1 correlates with Hypoxia
inducible-factor 1 alpha expression and lymphangiogenesis in
esophageal cancer. Thorac Cancer. 4:312–317. 2013.PubMed/NCBI View Article : Google Scholar
|
